The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.
Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
Women know that dairy, whole grains, fruits and vegetables are keys to a balanced diet – yet many aren't eating them because of the uncomfortable consequences that often occur when they do.
Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.
Aid-Tec recently introduced a unique bandage line that contains a breakable capsule that when broken releases a dose of a multi-compound therapeutic substance onto the bandage.
Infirst Healthcare on Wednesday announced the introduction of three new chocolate-flavored cough-cold items called Dr. Cocoa.
Arctic Ease, a company that makes cold and compression therapy products, announced Tuesday that it had launched its small joints wrap.
Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules.
Sandoz on Monday announced the introduction of tobramycin inhalation solution, USP into the U.S. market. The drug is an authorized generic version of Tobi from Novartis.